Results 151 to 160 of about 54,503 (167)

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Kfir Sharabi, Pere Puigserver
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Omid Veiseh, Benjamin C Tang, Kathryn A Whitehead   +2 more
exaly  

New-Onset Diabetes in Covid-19

New England Journal of Medicine, 2020
Francesco Rubino, Paul Z Zimmet, Stefan R Bornstein   +2 more
exaly  

Targeting the pancreatic β-cell to treat diabetes

Nature Reviews Drug Discovery, 2014
Amedeo Vetere, Amit Choudhary, Bridget K Wagner   +2 more
exaly  

SGLT2 inhibition — a novel strategy for diabetes treatment

Nature Reviews Drug Discovery, 2010
Robert R Henry
exaly  

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

Nature Reviews Drug Discovery, 2011
Frank D Waldron-Lynch, Kevan C Herold
exaly  

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2008
Anushka Patel, Stephen W Macmahon, John P Chalmers   +2 more
exaly  

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Y Donath, Steven E Shoelson
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Bernard Zinman Cm, Christoph Wanner, John M Lachin   +2 more
exaly  

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

New England Journal of Medicine, 2001
Jaakko Tuomilehto, Johan Gunnar Eriksson, Sirkka Aunola   +2 more
exaly